13F-HR filed by ACUTA CAPITAL PARTNERS, LLC
ACUTA CAPITAL PARTNERS, LLC filed this 13F-HR for the quarter ended 2024-06-30, filed 2024-08-14, with 33 holding rows worth $118,737,228.
- Accession
- 0001104659-24-089377
- Filer
- CIK 1582844
- Filed
- 2024-08-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q2 2024
A holdings report, 33 entries on the cover page, a total value of $118,737,228 stated on the cover page (in dollars after the unit check, H1), rows summing to $118,737,228 with VALUE read as dollars as filed, 13F file number 028-16527. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| OCULAR THERAPEUTIX INC | 67576A100 | COM | 2,771,130 | $18,954,529 | dollars as filed | |
| ENLIVEN THERAPEUTICS INC COM | 29337E102 | Stock | 397,698 | $9,294,202 | dollars as filed | |
| VAXCYTE INC COM | 92243G108 | Stock | 110,400 | $8,336,304 | dollars as filed | |
| DYNE THERAPEUTICS INC COM | 26818M108 | Stock | 212,500 | $7,499,125 | dollars as filed | |
| PRAXIS PRECISION MEDICINES I | 74006W207 | COM NEW | 164,431 | $6,800,866 | dollars as filed | |
| CRINETICS PHARMACEUTICALS INC COM | 22663K107 | Stock | 135,141 | $6,052,965 | dollars as filed | |
| ROCKET PHARMACEUTICALS INC | 77313F106 | COM | 250,370 | $5,390,466 | dollars as filed | |
| TAYSHA GENE THERAPIES INC | 877619106 | COMMON STOCK | 2,330,937 | $5,221,299 | dollars as filed | |
| REVOLUTION MEDICINES INC COM | 76155X100 | Stock | 133,000 | $5,161,730 | dollars as filed | |
| INSMED INC COM PAR $.01 | 457669307 | Stock | 72,100 | $4,830,700 | dollars as filed | |
| SAREPTA THERAPEUTICS INC | 803607100 | COM | 27,500 | $4,345,000 | dollars as filed | |
| Tourmaline Bio Inc | 89157D105 | Common Stock | 269,614 | $3,467,236 | dollars as filed | |
| AGIOS PHARMACEUTICALS INC | 00847X104 | COM | 78,700 | $3,393,544 | dollars as filed | |
| KURA ONCOLOGY INC COM | 50127T109 | Stock | 163,000 | $3,356,170 | dollars as filed | |
| Mersana Therapeutics Inc | 59045L106 | Common Stock | 1,663,000 | $3,342,630 | dollars as filed | |
| CORBUS PHARMACEUTICALS | 21833P301 | COM NEW | 64,500 | $2,918,625 | dollars as filed | |
| WHITEHAWK THERAPEUTICS INC | 00032Q104 | CMN | 1,849,402 | $2,700,127 | dollars as filed | |
| VIRIDIAN THERAPEUTICS INC | 92790C104 | COM | 199,433 | $2,594,623 | dollars as filed | |
| TERNS PHARMACEUTICALS INC COM | 880881107 | Stock | 369,280 | $2,514,797 | dollars as filed | |
| MEREO BIOPHARMA GROUP PLC | 589492107 | CMN | 677,000 | $2,437,200 | dollars as filed | |
| ARCELLX INC COMMON STOCK | 03940C100 | Stock | 42,200 | $2,329,018 | dollars as filed | |
| HELIX ACQUISITION CORP II | G4444H101 | CL A ORD SHS | 177,836 | $1,817,484 | dollars as filed | |
| ARGENX SE SPONSORED ADR | 04016X101 | ADR | 4,000 | $1,720,160 | dollars as filed | |
| TREVI THERAPEUTICS INC COM | 89532M101 | Stock | 260,000 | $774,800 | dollars as filed | |
| CELCUITY INC | 15102K100 | COM | 45,000 | $737,100 | dollars as filed | |
| ORIC PHARMACEUTICALS INC | 68622P109 | COM | 96,000 | $678,720 | dollars as filed | |
| PLIANT THERAPEUTICS INC | 729139105 | COM | 46,200 | $496,650 | dollars as filed | |
| RAPPORT THERAPEUTICS INC COM | 75383L102 | Stock | 20,000 | $465,200 | dollars as filed | |
| NEWAMSTERDAM PHARMA CO NV | N62509109 | COMMON STOCK | 22,500 | $432,225 | dollars as filed | |
| CYPHERPUNK TECHNOLOGIES INC | 52187K200 | COM NEW | 195,000 | $382,200 | dollars as filed | |
| CELLECTAR BIOSCIENCES INC | 15117F807 | COM | 70,500 | $176,250 | dollars as filed | |
| SAVARA INC | 805111101 | COM | 250 | $100,750 | dollars as filed | put |
| NUVATION BIO INC | 67080N119 | WARR | 90,832 | $14,533 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001104659-24-089377 | this filing | 2024-08-14 | acceptance time not in the bulk data set |